Hrt Financial LP Harpoon Therapeutics, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.55 - $0.82 $5,991 - $8,933	10,894 New	10,894 $7,000
Q2 2022 Aug 12, 2022	BUY	$1.78 - $5.02 $19,183 - $54,100	10,777 New	10,777 $20,000
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $442,664 - $609,150	-77,797 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $613,040 - $1.09 Million	77,797 New	77,797 $614,000
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $199,921 - $273,660	-11,327 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.83 - $17.84 $145,325 - $202,073	11,327 New	11,327 $188,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.